News
Press Releases25 February 2010
Ellex FY2010 Half Year Results and Highlights
Ellex today announced its audited financial results for the half year ended 31 December 2009. The Company delivered a strong performance during the first half of the 2010 financial year, achieving solid underlying profitability and positive cash flow despite a challenging economic environment.
9 February 2010
Market Update
Ellex today announced that the Company’s earnings performance in the first half of the 2010 financial year was better than anticipated, with unaudited Earnings Before Interest Tax and Depreciation (EBITDA) of $2.9 million, up 12% compared to the period ending December 2008 (excluding the impact of non-recurring items in the comparative period).
22 January 2010
Ellex Delivers Industry’s First Integrated Yellow Laser
Ellex today announced the launch of a new yellow laser photocoagulator, Integre Yellow™, at the 33rd Annual Meeting of the Japanese Society of Ophthalmic Surgeons (JSOS) in Tokyo.
17 December 2009
Trading Update
Ellex announced today that world wide sales of the Company's products have softened in the second quarter. As a result, it is expected that the Company's budget targets will not be met for the half year ending on 31 December 2009.
8 December 2009
Results of 2009 Annual General Meeting
Ellex is pleased to announce the results of resolutions put to the 2009 Annual General Meeting.
13 November 2009
Ellex 2RT™ Research Program Awarded Government Grant
Ellex announced today that the Ellex 2RT™ Research Program has been awarded a $0.54 million Victorian Government grant.
10 November 2009
Westpac Banking Facility Extended to 30 September 2011
Ellex today announced that it has extended its current banking facility with Westpac Banking Corporation. Under the agreement, Ellex has refinanced its core debt facility with Westpac to 30 September 2011.
23 October 2009
Ellex to Deliver New Generation Ultrasound at AAO
Ellex today announced that it will introduce the latest version of the Eye Cubed diagnostic ultrasound system at the annual meeting of the American Academy of Ophthalmology (AAO), October 24 – 27, 2009 in San Francisco.
27 August 2009
Ellex Releases Unaudited FY09 Year End Result
Ellex today announced its financial results for the year ended 30 June 2009.
10 June 2009
Ellex Reaches Milestone in SLT Laser Sales
Ellex today announced that it now has in place more than 1,000 SLT (Selective Laser Trabeculoplasty) laser systems on a global basis.
13 May 2009
Banking Facility Extended
Ellex today announced that the company’s banker, Westpac, has reviewed Ellex’s financial position and have issued a finance offer along similar lines to the existing arrangements that extends the facility until 31 August 2009, when it will again be reviewed.
1 April 2009
Ellex Appoints General Manager, Ellex Australia
Ellex today announced the appointment of John Edwards as General Manager of the Company’s Australian sales subsidiary, Ellex Australia.
26 February 2009
Ellex Reports Record First Half Revenue
Ellex today announced its financial results for the half year ended 31 December 2008. The result demonstrates continued growth in a challenging economic environment.
19 December 2008
Ellex Market Update
Ellex announced on the 31 October 2008 that foreign exchange (FOREX) hedging contracts entered into by the Company in July 2008 will impact the profitability of the Company in the current financial year.
1 December 2008
Ellex Announces Non-Renounceable Pro-Rata Rights Issue to Shareholders
Ellex announced today a non-renounceable pro-rata Rights Issue to shareholders of Ellex.
1 December 2008
Results of 2008 Annual General Meeting
Ellex announced today the results of resolutions put to the 2008 Annual General Meeting.
10 November 2008
Ellex Announces Six-Month Results on Retina Regeneration Therapy
Ellex today announced the six-month
clinical study results for the groundbreaking treatment Retina Regeneration Therapy (Ellex 2RT™) at the annual meeting of the American Academy of Ophthalmology.
4 November 2008
Ellex to Preview New Multi-Color Photocoagulation Laser at AAO
Ellex today announced that it will
preview a new, multi-color photocoagulation laser, Integre Pro™, at the upcoming American Academy of Ophthalmology (AAO), November 8-11, 2008 in Atlanta.
31 October 2008
Ellex to Review Foreign Exchange Hedging Contracts
Ellex announced today that the impact of Foreign Exchange (FOREX) hedging contracts entered into by the Company in July 2008 are likely to temper profits for this financial year
28 October 2008
Appointment of New Chief Financial Officer, Company Secretary
Ellex announced today the appointment of Melanie Young as Chief Financial Officer (CFO), effective immediately. Ellex also announced the appointment of Giuseppe Canala as Company Secretary. These appointments follow the departure of Tony Mitchell.
22 October 2008
Appointment of New CEO
Ellex announced today the appointment of Mr. Simon Luscombe as Group CEO, effective immediately. This follows the departure of Mr. Kevin McGuinness.
17 October 2008
Director and Advisor Appointments
Ellex announced today the appointment of Mr. Giuseppe Canala and Mr. Malcolm Plunkett to its board of directors. Ellex also announced the appointment of Mr. Warwick Kitt as an advisor to the company.
15 October 2008
Revised Date of Annual General Meeting
Ellex wishes to advise that it has
revised the date for the holding of the 2008 Annual General Meeting.
24 September 2008
Notice of Members' Resolution at General Meeting
Ellex wishes to advise that it has received an appropriately authorised Notice of Members’ Resolution under section 249N of the Corporations Act 2001 (Cth) from Intertec Healthcare Partners, L.P. and Dr Matthias Maus giving notice that they propose to move
the following motion at the Company’s Annual General Meeting
10 September 2008
Ellex commences direct sales in Germany
Ellex today announced another step in expanding its global reach with the establishment of a direct sales channel in Germany - Ellex Deutschland GmbH.
27 August 2008
Ellex FY08 Year End Results
Ellex today announced its financial results for the year ended 30 June 2008.
25 June 2008
Market Update - Position of CEO; Update on Outlook FY08
Ellex advises today that CEO Mr Peter Falzon has ceased employment with the Company with immediate effect.
14 May 2008
Outcome of Routine Tax Audit
Ellex advises today that the Australian Taxation Office (ATO)
routine audit of the Company has been completed with no adjustments required.
2 May 2008
Update on Outlook for FY08 Result
Ellex announced today that due to the difficult economic environment, sales growth and pre-tax earnings for the 2008 financial year are not expected to be as strong as previously advised.
3 March 2008
Ellex Appoints Tony Mitchell as CFO
Ellex announced today the appointment of Tony Mitchell as CFO and company secretary.
26 February 2008
Ellex FY2008 Half Year Results
Ellex announced today its financial results for the half year ended 31 December, 2007
31 January 2008
Update on FY08 First Half Result and Outlook for the Year
Ellex announced today that revenue growth in the first half of the 2008 Financial Year would exceed market guidance of 15% over the comparable period in 2007 with approximately 18% achieved.
28 November 2007
Results of 2007 Annual General Meeting
Ellex announced today the results of resolutions put to the 2007 Annual General Meeting.
23 November 2007
Ellex Appoints Warwick Kitt as a Director of Ellex Australia Pty Ltd
Ellex announced today that Warwick Kitt has joined the Board of Ellex Australia Pty Ltd.
10 November 2007
Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema
Ellex today announced clinical results of an ongoing study for non-thermal Retina Regeneration Therapy (Ellex 2RT™).
1 November 2007
Ellex Announces New Retina Regeneration Therapy to be Presented at the AAO
Ellex today announced that the initial results of treating patients with Retina Regeneration Therapy (Ellex 2RT™) will be presented by Peter Hamilton MD, FRCOph at the annual meeting of the American Academy of Ophthalmology.
15 October 2007
John Marshall and Kevin McGuinness Appointed to Ellex Board
Ellex announced today the appointment of Professor John Marshall and Kevin McGuinness to its board of directors to underpin the growth strategy of the company.
23 August 2007
Ellex FY2007 Year End Results
Ellex today announced its financial results for the year ended 30 June 2007.
2 August 2007
Ellex Appoints VP of U.S. Sales and Announces U.S. Expansion
Ellex announced today that effective September 1, 2007 it has appointed Ms Christin Harris as Vice President of U.S. Sales to lead its sales expansion in the United States.
26 june 2007
Ellex Raises $5.5 Million Through Placement
Ellex announced today that it raised $5.5 million through the placement of 6.5 million ordinary shares at a price of A$0.85 per share.
23 april 2007
ELLEX GAINS US FDA APPROVAL FOR 30XL LASER SLIT LAMP
FDA approval of the 30XL laser slit lamp represents another milestone in Ellex's stated strategy to be the leading brand of lasers to treat glaucoma, cataract and retinal conditions.
5 april 2007
ELLEX ENTERS CHINESE OPHTHALMIC LASER MARKET
Ellex has appointed GT Medical, a division of Guotong Holdings Company Limited as its exclusive distributor in China.
27 february 2007
FIRST HALF FY07 RESULTS
Results confirm that Ellex is gaining market share as a result of investments made in new products and distribution. Revenues grew by 26%, exceeding the estimated market growth rate of 5% per year, to $21.2 million. 14 february 2007
Awarded AusIndustry Grant
Awarded $1.9M AusIndustry Grant to Conduct AMD Laser Research 4 december 2006
ELLEX ACQUIRES INNOVATIVE IMAGING
Ellex announced today that it has acquired Innovative Imaging, Inc., a profitable U.S.-based leader in the design and manufacture of ophthalmic diagnostic ultrasound systems. 3 october 2006
ELLEX ESTABLISHES DIRECT SALES CHANNEL IN AUSTRALIA
Ellex commences trading of Ellex Australia Pty Ltd as a direct sales subsidiary that will sell the Ellex range of lasers direct to Australian ophthalmologists. 23 august 2006
FULL YEAR FY2006 RESULTS
Ellex returns to profitability on the back of strong revenue growth 21 august 2006
ELLEX TO ACQUIRE COHERENT LASERS AUSTRALIA
Ellex to market its ophthalmic lasers directly to ophthalmologists in Australia, New Zealand and the South Pacific 25 july 2006
ELLEX APPOINTS US LASER INDUSTRY VETERAN AS VP OPERATIONS
Herbert Pummer PhD, an accomplished laser industry veteran, appointed as Vice President of Operations 5 june 2006
ELLEX APPOINTS FIRST DIRECT SALESPERSON IN US
Ellex moves to direct sales in US with the appointment of Timothy Broome as Senior Territoy Manager. 27 april 2006
ELLEX APPOINTS NEW POSITION OF CHIEF OPERATING OFFICER
Kevin McGuinness appointed to the new position of Chief Operating Officer (COO). 11 april 2006
ELLEX RECEIVES FDA CLEARANCE FOR RED/GREEN PHOTOCOAGULATOR
Integre Duo, the industry's first solid-state red/green photocoagulator, receives 510(k) clearance 30 march 2006
Ellex TO PRESENT AT CITIGROUP MICROCAP CONFERENCE
April 4, 2006, Sydney, Australia 18 march 2006
Ellex Introduces New Retina Laser at the ASCRS Annual Meeting
Ellex to introduce the Integre Duo, the world’s first solid-state red and green photocoagulator, today at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting in San Francisco.
16 march 2006
Ellex Announces Rebranding and Shifts Focus to Direct Marketing of its Ophthalmic Lasers
Global Headquarters, led by CEO, to move to SF Bay Area
15 november 2005
AusIndustry Extends Research and Development Grant
AusIndustry has approved an additional grant of $0.4 million
7 november 2005
Impact of Transition to International Financial Reporting Standards (IFRS)
8 september 2005
Preliminary Final Report - 12 Months to 30 June 2005
Ellex Announces FY2005 Results
28 february 2005
Ellex Announces Restructure of Senior Management in line with Corporate Strategy
Ellex Medical today announced that it had restructured the senior management team, reflecting the Company's growth strategy, now in it's second year.
|
Ellex in the MediaDetection of Posterior Vitreous Detachment Using B-scan Ultrasound
Retina Today, November/December 2009
SLT Viable Option in Treating Primary Open-Angle Glaucoma
Ocular Surgery News, Europe Edition, November 2009
How SLT Fits Into My Refractive Practice
Cataract & Refractive Surgery Today Europe, October 2009
SLT’s Successful Clinical Implementation Will Rank Among Ophthalmology’s Milestones
Ophthalmology Times Europe, June 2009
Ellex Looks to Laser Retina Regeneration Therapy as Future for AMD
EuroTimes, January 2009
Study Shows Ellex 2RT Safe, Effective for Treating Diabetic Macular Edema
OSN Super Site, November 2008
Laser Treatment Shows Promise for Diabetic Macular Edema
Retina Today, July/August 2008
Laser Rejuvenates the Eye by Cleaning Up Bruch's Membrane, Surgeon Says
OSN Super Site, May 2008
New Laser Therapy Quickly Halts Diabetic Maculopathy: 2RT treats disease early & leaves photoreceptors unharmed
Ophthalmology Times Europe, April 2008
Better Iridotomies Prior to ICL Implantation: The Ultra Q laser offers significant advantages
Ophthalmology Management, March 2008
SLT: A New Option for Pseudoexfoliative Glaucoma
Ophthalmology Times Europe, January 2008
Using Laser Therapy for Diabetic Maculopathy and AMD
Ophthalmology Times, November 2007
CORRECTING CAPSULAR CONTRACTION AFTER CRYSTALENS IMPLANTATION
Cataract and Refractive Surgery Today, October 2007
INTEGRE DUO: THE WORLD'S FIRST SOLID-STATE PHOTOCOAGULATOR TO COMBINE VISIBLE RED AND GREEN
Medical Network, February 2007
SOLID-STATE SYSTEM BRINGS EFFICIENCY TO DUAL WAVELENGTH PHOTOCOAGULATION
Retinal Physician January/February 2007
WHAT'S AHEAD IN 2007, INTEGRE DUO LASER
Eyeworld December 2006 SLT EFFECTIVE AS BOTH A PRIMARY AND SECONDARY TREATMENT FOR GLAUCOMA
SLT A CONSISTENT AND EFFECTIVE TREATMENT
Ophthalmology Times September 11 2006 ELLEX STEPS OUT OF THE SHADOWS
Eyeworld July 2006 GLAUCOMA LASER ALLOWS REPEATED TREATMENTS
Eyeworld June 2004 |